Item 9 Labs

Item 9 Labs

Growth Stage

The First U.S. Vertically Integrated Cannabis Franchise.

The First U.S. Vertically Integrated Cannabis Franchise.


Raised to Date: Raised: $18,974

Total Commitments ($USD)


Dalmore Group

Start Date


Close Date

Not Provided

Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common


Series A

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Reporting Date


% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Alcohol, Tobacco, & Recreational Drugs

Tech Sector


Distribution Model




Capital Intensity



Phoenix, Arizona

Business Type


Item 9 Labs is raising funds on Dalmore Group through Reg A+ crowdfunding. The company makes and sells cannabis-derived products in licensed medical and adult-use dispensaries. The business also sells cannabis dispensary franchises under its franchise brand, Unity Rd. Item 9 Labs has won cannabis licenses in 17 states, over 45 cannabis and franchise industry awards, and more than 300 franchise awards in 15 countries. Andrew Bowden founded Item 9 Labs in 2010. The current crowdfunding campaign has no minimum target and a maximum target of $42,000,000. The campaign proceeds will be used for the acquisition of retail dispensary businesses, cultivation and production businesses, working capital, and general corporate purposes.

Balance Sheet

Cash and Cash Equivalents


Investment Securities


Total Investments


Accounts and Notes Receivable




Property, Plant and Equipment (PP&E)


Property and Equipment


Total Assets


Accounts Payable & Accrued Liabilities


Policy Liabilities and Accruals




Long Term Debt


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Total Revenues


Total Interest Income


Costs & Expenses Applicable to Rev


Total Interest Expenses


Depreciation and Amortization


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Auditor: BF Borgers CPA PC
Financials as of: 02/24/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Item 9 Labs on Dalmore Group 2022
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $133,057,658
Price per Share: $1.40

Follow company

Follow Item 9 Labs on Dalmore Group 2022

Buy Item 9 Labs's Deal Report

Warning: according to the close date for this deal, Item 9 Labs may no longer be accepting investments.

Item 9 Labs Deal Report

Get KingsCrowd’s comprehensive report on Item 9 Labs including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Item 9 Labs is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Item 9 Labs deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge